Molecular characterization of SMN copy number derived from carrier screening and from core families with SMA in a Chinese population

No abstract is available for this paper.

• Publication year

  2010

• Venue

  European Journal of Human Genetics

• Publication date

  2010-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ejhg.2010.54PMID 20442745PMCID PMC2987421
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Newborn Screening System Performance Evaluation Assessment Scheme (PEAS).

  2010cited by this paper
• Y chromosome haplotypes reveal prehistorical migrations to the Himalayas

  2009cited by this paper
• Genetic Carrier Screening for Spinal Muscular Atrophy and Spinal Muscular Atrophy with Respiratory Distress 1 in an Isolated Population in Israel

  2008cited by this paper
• Rapid prenatal diagnosis of spinal muscular atrophy by denaturing high‐performance liquid chromatography system

  2008cited by this paper
• Development and evaluation of a reverse dot blot assay for the simultaneous detection of six common Chinese G6PD mutations and one polymorphism.

  2008cited by this paper
• Analysis of point mutations in the SMN1 gene in SMA patients bearing a single SMN1 copy.

  2007cited by this paper
• Population screening and cascade testing for carriers of SMA

  2007cited by this paper
• Molecular analysis and prenatal prediction of spinal muscular atrophy in Chinese patients by the combination of restriction fragment length polymorphism analysis, denaturing high-performance liquid chromatography, and linkage analysis.

  2007cited by this paper
• Spinal muscular atrophy: from gene to therapy.

  2006cited by this paper
• Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease.

  2005cited by this paper
• Quantitative analysis of SMN1 and SMN2 genes based on DHPLC: A highly efficient and reliable carrier‐screening test

  2005cited by this paper
• New insights on the evolution of the SMN1 and SMN2 region: simulation and meta-analysis for allele and haplotype frequency calculations

  2004cited by this paper
• Genetic evidence supports demic diffusion of Han culture

  2004cited by this paper
• Detection of novel mutations in the SMN Tudor domain in type I SMA patients

  2004cited by this paper
• Carrier incidence for spinal muscular atrophy in southern Chinese

  2004cited by this paper
• Quantitative Analysis of SMN1 Gene and Estimation of SMN1 Deletion Carrier Frequency in Korean Population based on Real-Time PCR

  2004cited by this paper
• Prevalence of SMN1 deletion and duplication in carrier and normal populations: implication for genetic counselling

  2003cited by this paper
• Determination of SMN1 and SMN2 copy number using TaqMan™ technology

  2003cited by this paper
• Genetic testing and risk assessment for spinal muscular atrophy (SMA)

  2002cited by this paper
• Abnormal SMN1 gene copy number is a susceptibility factor for amyotrophic lateral sclerosis

  2002cited by this paper
• Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy.

  2002cited by this paper
• Genetic risk assessment in carrier testing for spinal muscular atrophy.

  2002cited by this paper
• An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA)

  2000cited by this paper
• A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2.

  1999cited by this paper
• Identification of a candidate modifying gene for spinal muscular atrophy by comparative genomics

  1998cited by this paper
• Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number.

  1997cited by this paper
• De novo rearrangements found in 2% of index patients with spinal muscular atrophy: mutational mechanisms, parental origin, mutation rate, and implications for genetic counseling.

  1997cited by this paper
• Identification and characterization of a spinal muscular atrophy-determining gene

  1995cited by this paper
• International SMA consortium meeting

  1992cited by this paper
• International SMA consortium meeting. (26-28 June 1992, Bonn, Germany).

  1992cited by this paper

• Comparative study of third-generation sequencing-based CASMA-trio and STR linkage analysis for identifying SMN1 2 + 0 carriers

  2025cites this paper
• Carrier Screening and Prenatal Diagnosis for Spinal Muscular Atrophy in Ningde City, Fujian Province

  2025cites this paper
• The Impact of Splicing Dysregulation on Neuromuscular Disorders and Current Neuromuscular Genetic Therapies

  2025cites this paper
• Incidence of Homozygous SMN2 Deletion in Japan: Cross-Reactivity of SMN2 Primers with SMN1 Sequence Causes False Negatives in Real-Time PCR Screening

  2025cites this paper
• Setting multidisciplinary intervention goals for spinal muscular atrophy patients utilizing the international classification of functioning, disability, and health: a pilot study in a small sample sizes

  2025cites this paper
• A de novo deletion underlying spinal muscular atrophy: implications for carrier testing and genetic counseling

  2025cites this paper
• The prevalence of SMN gene deletion/duplication in spinal muscular atrophy families referred to neuro-genetic centers of Mashhad, Iran

  2024cites this paper
• Subjective Valuation of Screening for Spinal Muscular Atrophy and Analysis of its Influencing Factors: Evidence from Iran

  2024cites this paper
• A Post-Marketing Surveillance Study of Nusinersen for Spinal Muscular Atrophy in Routine Medical Practice in China: Interim Results

  2024cites this paper
• Analysis of spinal muscular atrophy carrier screening results in 32,416 pregnant women and 7,231 prepregnant women

  2024cites this paper
• Real-World Outcomes in Patients with Spinal Muscular Atrophy Treated with Onasemnogene Abeparvovec Monotherapy: Findings from the RESTORE Registry

  2024cites this paper
• Real-world evidence: Risdiplam in a patient with spinal muscular atrophy type I with a novel splicing mutation and one SMN2 copy

  2024cites this paper
• Comprehensive copy number analysis of spinal muscular atrophy among the Iranian population

  2024cites this paper
• Correlation analysis of LXR and its target genes COX2 and CETP with the severity of OSAHS in obese young rats

  2024cites this paper
• Development and validation of a one-step SMN assay for genetic testing in spinal muscular atrophy via MALDI-TOF MS.

  2024cites this paper
• SMN2 gene copy number affects the incidence and prognosis of motor neuron diseases in Japan

  2024cites this paper
• Outcomes for patients in the RESTORE registry with spinal muscular atrophy and four or more SMN2 gene copies treated with onasemnogene abeparvovec.

  2024cites this paper
• Spinal muscular atrophy type I associated with a novel SMN1 splicing variant that disrupts the expression of the functional transcript

  2023influential citation
• 中国新生儿筛查进展

  2023cites this paper
• The Carrier Frequency of Two SMN1 Genes in Parents of Symptomatic Children with SMA and the Significance of SMN1 Exon 8 in Carriers

  2023cites this paper
• Comprehensive analysis of spinal muscular atrophy (CASMA): SMN1 copy number, intragenic mutation and 2 + 0 carrier analysis by third-generation sequencing.

  2022cites this paper
• Comprehensive profile and natural history of pediatric patients with spinal muscular atrophy: A large retrospective study from China

  2022cites this paper
• Simultaneous quantification of SMN1 and SMN2 copy numbers by MALDI-TOF mass spectrometry for spinal muscular atrophy genetic testing.

  2022cites this paper
• Physical Therapy for Type III Spinal Muscular Atrophy in a Uyghur Pedigree

  2021cites this paper
• Genomic Variability in the Survival Motor Neuron Genes (SMN1 and SMN2): Implications for Spinal Muscular Atrophy Phenotype and Therapeutics Development

  2021cites this paper
• Matching-adjusted indirect treatment comparison of onasemnogene abeparvovec and nusinersen for the treatment of symptomatic patients with spinal muscular atrophy type 1

  2021cites this paper
• Case Report: Whole-Exome Sequencing With MLPA Revealed Variants in Two Genes in a Patient With Combined Manifestations of Spinal Muscular Atrophy and Duchenne Muscular Dystrophy

  2021cites this paper
• Transmission characteristics of SMN from 227 spinal muscular atrophy core families in China

  2020cites this paper
• The analysis of the association between the copy numbers of survival motor neuron gene 2 and neuronal apoptosis inhibitory protein genes and the clinical phenotypes in 40 patients with spinal muscular atrophy

  2020cites this paper
• Carrier Frequency of Spinal Muscular Atrophy in a Large-scale Korean Population

  2020cites this paper
• Dual Mechanism of a New SMN1 Variant (c.835G>C, p.Gly279Arg) by Interrupting Exon 7 Skipping and YG Oligomerization in Causation of Spinal Muscular Atrophy

  2020cites this paper
• NGS-based spinal muscular atrophy carrier screening of 10,585 diverse couples in China: a pan-ethnic study

  2020cites this paper
• Carrier Screening of 400 Variations Related 11 Recessive Diseases in the Daur Ethnicity in China

  2020cites this paper
• Dual Mechanism of a New SMN1 Variant (c.835G>C, p.Gly279Arg) by Interrupting Exon 7 Skipping and YG Oligomerization in Causation of Spinal Muscular Atrophy

  2020cites this paper
• High-throughput analysis revealed mutations’ diverging effects on SMN1 exon 7 splicing

  2019cites this paper
• The frequency of SMN gene variants lacking exon 7 and 8 is highly population dependent

  2019cites this paper
• High-throughput screening reveals novel mutations in spinal muscular atrophy patients

  2019cites this paper
• [Association of copy number of SMN1 and SMN2 with clinical phenotypes in children with spinal muscular atrophy].

  2019cites this paper
• Identification of novel SMN1 subtle mutations using an allelic-specific RT-PCR.

  2019cites this paper
• Muscle Atrophy in Cancer.

  2018cites this paper
• Mechanism of Splicing Regulation of Spinal Muscular Atrophy Genes.

  2018cites this paper
• The next generation of population-based spinal muscular atrophy carrier screening: comprehensive pan-ethnic SMN1 copy-number and sequence variant analysis by massively parallel sequencing

  2017cites this paper
• Survival motor neuron 1 (SMN1) gene acts as a promising prognostic biomarker for potential spinal muscular atrophy in the Chinese population

  2017cites this paper
• Liver X Receptor Gene Expression is Enhanced in Children with Obstructive Sleep Apnea-Hyperpnoea Syndrome and Cyclooxygenase-2 (COX-2) is Correlated with Severity of Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS)

  2017cites this paper
• p.Val19Glyfs*21 and p.Leu228* variants in the survival of motor neuron 1 trigger nonsense-mediated mRNA decay causing the SMN1 PTC+ transcripts degradation.

  2017cites this paper
• Inherited Neurological Disorders

  2017cites this paper
• Notable Carrier Risks for Individuals Having Two Copies of SMN1 in Spinal Muscular Atrophy Families with 2-copy Alleles: Estimation Based on Chinese Meta-analysis Data

  2017cites this paper
• The Contribution of the PCR-Enzymatic Digestion in the Positive Diagnosis of Proximal Spinal Muscular Atrophy in the Moroccan Population

  2017cites this paper
• Evaluation and comparison of three assays for molecular detection of spinal muscular atrophy

  2017cites this paper
• Prevalence, incidence and carrier frequency of 5q–linked spinal muscular atrophy – a literature review

  2017cites this paper
• Application of urine cells in drug intervention for spinal muscular atrophy

  2017cites this paper
• Motor Neuron-Related Disorders

  2017cites this paper
• Competitive PCR for Copy Number Assessment by Restricting dNTPs

  2017cites this paper
• Mutation Spectrum of the Survival of Motor Neuron 1 and Functional Analysis of Variants in Chinese Spinal Muscular Atrophy.

  2016cites this paper
• Association of Copy Numbers of Survival Motor Neuron Gene 2 and Neuronal Apoptosis Inhibitory Protein Gene With the Natural History in a Chinese Spinal Muscular Atrophy Cohort

  2015cites this paper
• Copy number assessment by competitive PCR with limiting deoxynucleotide triphosphates and high-resolution melting.

  2015cites this paper
• Molecular characterization and copy number of SMN1, SMN2 and NAIP in Chinese patients with spinal muscular atrophy and unrelated healthy controls

  2015cites this paper
• CHARACTERIZATION OF MOLECULAR ISOFORMS AND ROLE OF THE SURVIVAL MOTOR NEURON (SMN) IN MOTOR NEURONS DISEASES

  2014cites this paper
• Advances in therapeutic development for spinal muscular atrophy.

  2014cites this paper
• Molecular Prenatal Diagnosis of Autosomal Recessive Spinal Muscular Atrophies Using Quantification Polymerase Chain Reaction

  2013cites this paper
• Spinal muscular atrophy carrier frequency in Ukraine

  2013cites this paper
• Spinal Muscular Atrophy: From Gene Discovery to Clinical Trials

  2013cites this paper
• Molecular analysis of the SMN gene mutations in spinal muscular atrophy patients in China.

  2013influential citation
• Molecular analysis of SMN1, SMN2, NAIP, GTF2H2, and H4F5 genes in 157 Chinese patients with spinal muscular atrophy.

  2013cites this paper
• Molecular analysis of SMN 1 , SMN 2 , NAIP , GTF 2 H 2 , and H 4 F 5 genes in 157 Chinese patients with spinal muscular atrophy ☆

  2013cites this paper
• The Natural History of Infant Spinal Muscular Atrophy in China

  2012cites this paper
• Subtle mutations in the SMN1 gene in Chinese patients with SMA: p.Arg288Met mutation causing SMN1 transcript exclusion of exon7

  2012cites this paper
• Modification of phenotype by SMN2 copy numbers in two Chinese families with SMN1 deletion in two continuous generations.

  2012cites this paper
• Frecuencia de algunas enfermedades genéticas en Neuropediatría

  2012cites this paper
• Detection of Spinal Muscular Atrophy Carriers in a Sample of the Brazilian Population

  2011cites this paper
• Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72 400 specimens

  2011cites this paper
• Establishment of a molecular diagnostic system for spinal muscular atrophy experience from a clinical laboratory in china.

  2011cites this paper
• Large-scale population screening for spinal muscular atrophy: Clinical implications

  2011cites this paper
• Chinese guidelines for three levels of prevention of spinal muscular atrophy

  year unknowncites this paper